Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$837.29 5.53 (0.66%) as of 4:30 Thu 6/6


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 800.93(B)
Last Volume: 2,108,588 Avg Vol: 3,278,293
52 Week Range: $434.7 - $815.06
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:

    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 698,556 1,568,556 3,207,712 6,168,224
Total Sell Value $569,078,450 $1,176,763,830 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 11 23 50 90
End Date 2024-03-08 2023-12-06 2023-06-07 2022-06-07

   
Records found: 3315
  Page 10 of 133  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Ricks David A President, Chair, and CEO   •       •      –    2023-02-10 4 A $345.12 $19,398,505 D/D 56,208 443,751     -
   Jonsson Patrik EVP&Pres, LLY Imm, LLY USA&CCO   •       –      –    2023-02-10 4 A $345.12 $2,721,616 D/D 7,886 42,941     -
   Ashkenazi Anat EVP & CFO   •       –      –    2023-02-10 4 A $345.12 $2,309,888 D/D 6,693 38,120     -
   Van Naarden Jacob EVP and CEO Loxo@Lilly   •       –      –    2023-02-10 4 A $345.12 $830,704 D/D 2,407 10,374     -
   Hernandez Edgardo EVP & Pres., Mfg. Operations   •       –      –    2023-02-10 4 A $345.12 $1,796,004 D/D 5,204 25,814     -
   Ricks David A President, Chair, and CEO   •       •      –    2023-02-08 4 GD $0.00 $0 D/D 4,200 387,543     -
   Norton Johna EVP, Global Quality   •       –      –    2023-02-01 4 D $344.15 $323,845 D/D (941) 31,401     -
   Norton Johna EVP, Global Quality   •       –      –    2023-02-01 4 OE $0.00 $0 D/D 2,102 32,342     -
   Jonsson Patrik EVP&Pres, LLY Imm, LLY USA&CCO   •       –      –    2023-02-01 4 D $344.15 $1,031,418 D/D (2,997) 35,055     -
   Jonsson Patrik EVP&Pres, LLY Imm, LLY USA&CCO   •       –      –    2023-02-01 4 OE $0.00 $0 D/D 6,690 38,052     -
   Skovronsky Daniel EVP, CS&MO & Pres., LRL   •       –      –    2023-02-01 4 D $344.15 $2,421,095 D/D (7,035) 87,199     -
   Skovronsky Daniel EVP, CS&MO & Pres., LRL   •       –      –    2023-02-01 4 OE $0.00 $0 D/D 15,675 94,234     -
   Pusey Leigh Ann EVP, Corp. Affairs & Comm.   •       –      –    2023-02-01 4 D $344.15 $494,888 D/D (1,438) 27,960     -
   Pusey Leigh Ann EVP, Corp. Affairs & Comm.   •       –      –    2023-02-01 4 OE $0.00 $0 D/D 3,154 29,398     -
   Hakim Anat EVP, GC & Secretary   •       –      –    2023-02-01 4 D $344.15 $1,167,701 D/D (3,393) 13,117     -
   Hakim Anat EVP, GC & Secretary   •       –      –    2023-02-01 4 OE $0.00 $0 D/D 7,646 16,510     -
   Mason Michael B EVP & Pres., Lilly Diabetes   •       –      –    2023-02-01 4 D $344.15 $1,010,080 D/D (2,935) 31,261     -
   Mason Michael B EVP & Pres., Lilly Diabetes   •       –      –    2023-02-01 4 OE $0.00 $0 D/D 6,690 34,196     -
   Ricks David A President, Chair, and CEO   •       •      –    2023-02-01 4 D $344.15 $7,350,700 D/D (21,359) 391,743     -
   Ricks David A President, Chair, and CEO   •       •      –    2023-02-01 4 OE $0.00 $0 D/D 47,786 413,102     -
   White Anne E. EVP & Pres, Lilly Neuroscience   •       –      –    2023-02-01 4 D $344.15 $1,119,176 D/D (3,252) 54,364     -
   White Anne E. EVP & Pres, Lilly Neuroscience   •       –      –    2023-02-01 4 OE $0.00 $0 D/D 7,264 57,616     -
   Alvarez Ralph Director   –       •      –    2023-01-17 4 A $357.74 $11,448 D/D 32 52,738     -
   Tai Jackson P Director   –       •      –    2023-01-17 4 A $357.74 $2,146 D/D 6 63,450     -
   Johnson Kimberly H Director   –       •      –    2023-01-17 4 A $357.74 $9,659 D/D 27 1,981     -

  3315 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 133
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed